A detailed history of Avantax Advisory Services, Inc. transactions in Mckesson Corp stock. As of the latest transaction made, Avantax Advisory Services, Inc. holds 5,098 shares of MCK stock, worth $2.46 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
5,098
Previous 1,674 204.54%
Holding current value
$2.46 Million
Previous $898,000 231.51%
% of portfolio
0.02%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$518.81 - $607.81 $1.78 Million - $2.08 Million
3,424 Added 204.54%
5,098 $2.98 Million
Q1 2024

May 08, 2024

SELL
$473.42 - $539.26 $81,901 - $93,291
-173 Reduced 9.37%
1,674 $898,000
Q4 2023

Feb 07, 2024

BUY
$437.42 - $470.64 $134,725 - $144,957
308 Added 20.01%
1,847 $855,000
Q3 2023

Nov 07, 2023

SELL
$402.4 - $446.42 $10,462 - $11,606
-26 Reduced 1.66%
1,539 $669,000
Q2 2023

Aug 11, 2023

SELL
$354.01 - $427.31 $851,394 - $1.03 Million
-2,405 Reduced 60.58%
1,565 $668,000
Q1 2023

Apr 28, 2023

BUY
$335.35 - $386.06 $235,415 - $271,014
702 Added 21.48%
3,970 $1.41 Million
Q4 2022

Feb 13, 2023

SELL
$346.68 - $397.58 $116,484 - $133,586
-336 Reduced 9.32%
3,268 $1.23 Million
Q3 2022

Nov 01, 2022

BUY
$321.25 - $373.84 $247,362 - $287,856
770 Added 27.17%
3,604 $1.23 Million
Q2 2022

Aug 02, 2022

BUY
$300.57 - $336.42 $245,565 - $274,855
817 Added 40.51%
2,834 $924,000
Q1 2022

Apr 27, 2022

BUY
$244.61 - $310.48 $200,580 - $254,593
820 Added 68.5%
2,017 $619,000
Q4 2021

Jan 24, 2022

BUY
$198.21 - $248.9 $237,257 - $297,933
1,197 New
1,197 $298,000
Q4 2020

Jan 22, 2021

SELL
$143.79 - $183.66 $292,756 - $373,931
-2,036 Closed
0 $0
Q3 2020

Oct 14, 2020

BUY
$140.89 - $159.9 $286,852 - $325,556
2,036 New
2,036 $304,000

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $69.3B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Avantax Advisory Services, Inc. Portfolio

Follow Avantax Advisory Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avantax Advisory Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Avantax Advisory Services, Inc. with notifications on news.